New and Revised FDA Import Alerts for Feb. 28
On Feb. 28, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
- 99-05: Raw Agricultural Products for Pesticides (here)
- 68-20: Xylazine Active Pharmaceutical Ingredient (API) and Unapproved Finished Drug Products Containing Xylazine (here)
- 66-79: Drugs from Foreign Establishments Refusing FDA Inspection (here)
- 53-06: Cosmetics that are Adulterated and/or Misbranded due to Color Additive Violations (here)
- 45-02: Foods Containing Illegal and/or Undeclared Colors (here)
- 16-125: Refrigerated (Not Frozen) Raw Fish and Fishery Products that are Vacuum Packaged or Modified Atmosphere Packaged or Packaged in a Material that is not Oxygen-Permeable due to the Potential for Clostridium Botulinum Toxin Production (here)
- 16-74: Uneviscerated Fish or Partially Eviscerated Fish that are Either Salt-Cured, Dried, Smoked, Pickled, Fermented or Brined (here)
- 16-50: Molluscan Bivalve Shellfish (here)
- 16-35: Raw and Cooked Shrimp from India (here).